Futura medical begins recruitment for med2002 safety trial youtube. Futura medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal dermasys technology. Brought to us by futura medical the med2002 or also known under its brand name eroxon, this is a new and improved topical treatment for erectile dysfunction that can help men all over the world. Futura medical looking ahead to completion of key phase iii ed trial. Fum james barder tells proactive the company has seen a very good year of progress with its med2002 erectile dysfunction gel as. Futura medical plc raises funds to finance its erectile dysfunction. Fum james barder tells proactive the company has seen a very good year of progress with its med2002 erectile dysfunction gel as the company reports its half year results. Futura medical plcs phase 3 data for med2005 could drive. This product uses the med2002 topical gel formulation and incorporates dermasys futura medical plc. Get a free 7 day trial of medical billing software.
London alliance news pharmaceutical firm futura medical plc said wednesday it has enrolled its first patient on a latestage clinical trial of its med2002 erectile dysfunction treatment. Founded in a basement in 1979, epic develops software to help people get well, help people stay well, and help future generations be healthier. It lays primary focus exclusively on topically applied pharmaceutical drugs and. User friendly, easy to use, and affordable medical practice management system for physicians and medical professionals. The first european phase 3 study for med2002, referred to as fm57, is a 1,000 patient. Futura medical plc is a major drug manufacturer based in the united kingdom. Fum, the innovative healthcare company focused on advanced transdermal technology, is pleased to announce positive data from its pharmacokinetic pk study fm58 of med2002, the companys topical gel for erectile dysfunction ed. The futura medical med2002 solution provides an effective alternative to dangerous surgical operations or oral medication. Kincora copper begins drilling program at trundle project in new south wales. The following slide deck was published by futura medical plc in conjunction with this event. Futura has a proven track record in delivery and completion of. Topical alprostadil cream for the treatment of erectile dysfunction.
Med2002 is male enhancement gel that has been designed to be applied topically on the male organ to help treat erectile dysfunction. Med2005 or med2002 are the codename s used by futura for all proprietary formulations of gtn. Med2002 is the codename used by futura for all proprietary formulations of gtn. Fum, tells proactive theyve begun recruitment for a pharmacokinetic study of their. Futura medical is developing a portfolio of innovative products for two large markets, sexual health and pain.
Fum, tells proactive theyve begun recruitment for a pharmacokinetic study of their lead product, med2002. Futura medical shifts focus to med2002 treatment as. Fum james barder tells proactive the company has seen a very good year of progress with its med2002 erectile dysfunction gel as the company reports its half year. Guildfordbased futura medicals med2002, branded as eroxon, could be set to overtake viagra as the goto erectile dysfunction treatment. Futura medical famdf med2002 treatment for erectile. Fum, the innovative healthcare company focused on advanced transdermal technology, is pleased to announce the outcome of the detailed analysis of the results of the recent. Futura medical plc shifts focus to med2002 treatment as. Futura medical plc looking ahead to completion of key phase iii ed. Gel that works on erectile dysfunction in just five. Equity research, broker reports, and media content available to private and noninstitutional investors. Efficacy and safety of med2005, a topical glyceryl trinitrate. James barder, chief executive of futura medical plc lon. Futura medical plc says it may have found simpler route to.
Fum complete futura medical plc stock news by marketwatch. Futura medical plc is a united kingdombased pharmaceutical company that develops products for consumer healthcare. The directors plan to take med2002 through phase 3 development and then. Futura medical begins recruitment for med2002 safety trial. Its main ingredient is glyceryl trinitrate, which is known to be a powerful vasodilator.
Software firm sopheon suffered a shock, tumbling 19 per cent to. Eroxon is the registered and suggested brand name for futura s topical gel for ed, though potential distributors may choose to use other brand names. Futura medical endured a bittersweet week following a surprising result. Headline results from the trial of med2005 are due before the end of 2019, while futura is also confident of hearing back from uk regulators. Futura medical plcs data from a phase 3 trial of its med2005 erectile dysfunction treatment could drive the share price up over 500% according to analysts at. Futura medical med2002 a new gel treatment for erectile. Futura medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal dermasys drug delivery technology. Futura medical is the pharmaceutical company that is behind this male sexual enhancement gel. Webfg news advanced transdermal technologyfocussed healthcare company futura medical updated the market on the planned phase iii trials for med 2002. Level the playing field with access to the latest investment research. Futura medical presents data on med2005 for the treatment of. Consisting of a topical lotion that is applied to the glans of the penis, med2002 is non irritant, non invasive, discreet, and easy to apply. Med3000 is now the codename for a formulation of dermasys developed specifically for the treatment of ed. Futura medical plc positive data from med2002 pk study.
1423 960 1387 1074 1578 493 1461 1024 994 1603 833 55 423 297 688 1083 663 1181 4 430 214 1452 764 1558 598 953 1083 598 629 605 288 449 686 238 338 437 487